FIN Committee Session, 1/15/2026 #1
Finance Committee · January 7, 2026
Finance Committee briefing on Jan. 15 heard from the Prescription Drug Affordability Board on its cost-review work, preliminary affordability determinations for two diabetes drugs and related policy options, followed by a briefing from the Office of Financial Regulation on digital assets, virtual-currency kiosks, earned-wage-access and AI oversight.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.